Surgical Antibiotic Prophylaxis and Clostridium difficile Toxin Positivity
Daniel Kreisel, MD;
Thomas G. Savel, MD;
Alan L. Silver, MD, MPH;
John D. Cunningham, MD
Arch Surg. 1995;130(9):989-993.
Abstract
| |
Objective
To examine a possible relationship between prophylactic antibiotic therapy (PAT) and the development of Clostridium difficile toxin (CDT) positivity.
Design
Retrospective case-control study.
Setting
Tertiary care medical center in New York, NY.
Patients
A total of 357 patients, admitted from November 1992 to April 1994, with positive CDT assays. Of these, 23 patients (6%) received only PAT for elective surgical procedures. Thirty-nine patients were matched as controls for age, sex, and surgical procedure.
Main Outcome Measures
Both CDT positivity and inappropriate use of PAT.
Results
Appropriate PAT was used in 26 (42%) of 62 patients (17% cases, 56% controls). The Mantel-Haenszel estimator for the summary odds ratio for the development of CDT positivity from inappropriate use of PAT was 5.1 (95% confidence interval, 1.10 to 23.64). Mean duration between the operation and the final antibiotic dose was significantly longer in the CDT-positive group compared with the control group (3.1 vs 1.7 days, P<.05). The length of hospital stay was significantly longer in the CDT-positive group compared with the control group (16.5 vs 10.2 days, P<.05).
Conclusions
The prolonged use of PAT in elective surgical cases increases the risk of developing CDT positivity. The appropriate use of PAT could significantly reduce health costs by eliminating unnecessary doses of antibiotics, by decreasing the rate of CDT positivity, and by shortening the hospital stay. Restrictive policies may need to be implemented to prevent further antibiotic misuse.
(Arch Surg. 1995;130:989-993)
Author Affiliations
From the Departments of Surgery (Drs Kreisel, Savel, and Cunningham) and Community Medicine (Dr Silver), Mount Sinai School of Medicine, New York, NY.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Implementing 1-Dose Antibiotic Prophylaxis for Prevention of Surgical Site Infection
Fonseca et al.
Arch Surg 2006;141:1109-1113.
ABSTRACT
| FULL TEXT
The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: Duration
Edwards et al.
Ann. Thorac. Surg. 2006;81:397-404.
FULL TEXT
Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review
Thomas et al.
J Antimicrob Chemother 2003;51:1339-1350.
ABSTRACT
| FULL TEXT
Clostridium difficile Colitis: An Increasingly Aggressive Iatrogenic Disease?
Morris et al.
Arch Surg 2002;137:1096-1100.
ABSTRACT
| FULL TEXT
Prolonged Antibiotic Prophylaxis After Cardiovascular Surgery and Its Effect on Surgical Site Infections and Antimicrobial Resistance
Harbarth et al.
Circulation 2000;101:2916-2921.
ABSTRACT
| FULL TEXT
Diarrhea and Clostridium difficile--Associated Diarrhea on a Surgical Service
McCarter et al.
Arch Surg 1996;131:1333-1337.
ABSTRACT
|
